Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Port-Wine Stain: early-phase trial registry
2 of 3 indexed Port-Wine Stain trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Port-Wine Stain: 3 US clinical trials tracked, 2 recruiting.
Port-Wine Stain is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., running 1 of these trials.
Enrollment posture brief
Registry condition port-wine-stain
OPEN 2 | RECR 67% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Port-Wine Stain lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Port-Wine Stain on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Port-Wine Stain is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.
NCT05171894
Tolerability of 532 nm Laser Treatment of Port Wine Stains
Massachusetts General Hospital
NCT05841628
Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences
University of California, Irvine
NCT00540371
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Port-Wine Stain records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Port-Wine Stain trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Port-Wine Stain page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Port-Wine Stain trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. sponsors the most Port-Wine Stain trials on record, review their full trial history before evaluating a specific study. See Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Port-Wine Stain condition card totals 3 registered trials; most-linked intervention Port wine stain Birthmark; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.